Piwnica, David
Pathak, Atul
Schäfer, Gregor
Docherty, James R.
Article History
First Online: 27 January 2018
Compliance with Ethical Standards
:
: This study was supported by Nestle Skin Health R&D, Sophia Antipolis, France.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: DP and GS are full-time employees of Nestle Skin Health/Galderma. AP has received consulting fees from Galderma for advisory meetings and manuscript writing and reviewing. JRD has served as an advisory board member for Galderma Laboratories. Galderma markets a brimonidine product for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.